These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 36845292)

  • 21. Prevalence of Cardiovascular Complications in Individuals with Sickle Cell Anemia and Other Hemoglobinopathies: A Systematic Review.
    Lopes A; Dantas MT; Ladeia AMT
    Arq Bras Cardiol; 2022 Dec; 119(6):893-899. PubMed ID: 36417618
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Total hip arthroplasty for osteonecrosis of the femoral head in sickle cell disease: a case series from our African experience.
    Rossi G; Maffulli N; Lombardo MDM; Manfroni F; Bassani R; Petrachi BV; Sirtori P; Brugnoli A; Cuccuru T; Brambilla L; Domenicucci M; Marmotti A; Dzissah OEK; Mangiavini L; Kombate NK; Peretti GM
    J Biol Regul Homeost Agents; 2020; 34(4 Suppl. 3):219-222. Congress of the Italian Orthopaedic Research Society. PubMed ID: 33261281
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Treatment of sickle cell disease's hip necrosis by core decompression: a prospective case-control study.
    Mukisi-Mukaza M; Manicom O; Alexis C; Bashoun K; Donkerwolcke M; Burny F
    Orthop Traumatol Surg Res; 2009 Nov; 95(7):498-504. PubMed ID: 19801210
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The pattern of sickle cell disease in pregnancy in Lagos, Nigeria.
    Ogedengbe OK; Akinyanju O
    West Afr J Med; 1993; 12(2):96-100. PubMed ID: 8398940
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Profile of Reproductive Issues Associated with Different Sickle Cell Disease Genotypes.
    Carvalho FA; Souza AI; Ferreira ALCG; Neto SDS; Oliveira ACPL; Gomes MLRP; Costa MFH
    Rev Bras Ginecol Obstet; 2017 Aug; 39(8):397-402. PubMed ID: 28683515
    [No Abstract]   [Full Text] [Related]  

  • 26. Total Hip Arthroplasty in Patients With Sickle Cell Disease: A Comprehensive Systematic Review.
    Fassihi SC; Lee R; Quan T; Tran AA; Stake SN; Unger AS
    J Arthroplasty; 2020 Aug; 35(8):2286-2295. PubMed ID: 32376165
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Early Outcomes of Primary Total Hip Arthroplasty for Osteonecrosis of the Femoral Head in Patients with Human Immunodeficiency Virus in China.
    Zhao CS; Li X; Zhang Q; Sun S; Zhao RG; Cai J
    Chin Med J (Engl); 2015 Aug; 128(15):2059-64. PubMed ID: 26228219
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Osteonecrosis of the hip: is there a difference in the survivorship of total hip arthroplasty with or without previous vascular iliac bone grafting?
    Chau WW; Ng JP; Lau HW; Ong MT; Chung KY; Ho KK
    J Orthop Surg Res; 2021 Apr; 16(1):244. PubMed ID: 33832513
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of pneumococcal vaccination response in children with sickle cell disease: HbSS and HbSC.
    Le Ng X; Alikhan M; Stark JM; Mosquera RA; Shahrukh Hashmi S; Gonzales T; Brown DL; Nguyen TT; Yadav A
    Allergol Immunopathol (Madr); 2019; 47(6):564-569. PubMed ID: 31164233
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Plasma Interleukin-33 Cannot Predict Hip Osteonecrosis in Patients With Sickle Cell Disease: A Case-Control Study.
    Agrawal AC; Mohapatra E; Nanda R; Bodhey NK; Sakale H; Garg AK
    Cureus; 2022 Mar; 14(3):e23556. PubMed ID: 35371856
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prevalence of hemoglobinopathy disorders in adult patients sent for diagnosis of anemia in saudi arabia.
    Alsaeed AH
    Genet Test Mol Biomarkers; 2012 Jan; 16(1):25-9. PubMed ID: 21861712
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of Sickle Cell Trait on Total Hip Arthroplasty in a Matched Cohort.
    Waters TL; Wilder JH; Ross BJ; Salas Z; Sherman WF
    J Arthroplasty; 2022 May; 37(5):892-896.e5. PubMed ID: 35026366
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Borderline Developmental Dysplasia of the Hip: A Risk Factor Predicting the Development and Poor Prognosis after Core Decompression for Idiopathic Osteonecrosis of the Femoral Head.
    Huang K; Zhang QY; He HY; Gao CX; Wang G; Yang J; Xie HQ; Zeng Y
    Orthop Surg; 2022 Oct; 14(10):2427-2435. PubMed ID: 35981313
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hemoglobinopathy Patterns in Anemic Patients with a Strong History of Sickle Cell Disease in Eastern Province, Saudi Arabia: A Cross-Sectional Study.
    Mohammed EI; Elmosaad YM; Waggiallah HA
    Pak J Biol Sci; 2022 Nov; 25(12):1094-1099. PubMed ID: 36978277
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Alumina-alumina total hip arthroplasty for the sequelae of Legg-Calve-Perthes disease: A comparative study with adult-onset osteonecrosis.
    Lee SJ; Yoo JJ; Kim HJ
    J Orthop Sci; 2016 Nov; 21(6):836-840. PubMed ID: 27522609
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Sickle cell disease: A distinction of two most frequent genotypes (HbSS and HbSC).
    da Guarda CC; Yahouédéhou SCMA; Santiago RP; Neres JSDS; Fernandes CFL; Aleluia MM; Figueiredo CVB; Fiuza LM; Carvalho SP; Oliveira RM; Fonseca CA; Ndidi US; Nascimento VML; Rocha LC; Goncalves MS
    PLoS One; 2020; 15(1):e0228399. PubMed ID: 31995624
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Assessment of the use of transfusion therapy perioperatively in patients with sickle cell hemoglobinopathies.
    Bischoff RJ; Williamson A; Dalali MJ; Rice JC; Kerstein MD
    Ann Surg; 1988 Apr; 207(4):434-8. PubMed ID: 3355266
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Intraoperative Periprosthetic Fractures in Total Hip Arthroplasty in Patients With Sickle Cell Disease at King Fahad Hospital Hofuf: A Cross-Sectional Study.
    Alsaleem MK; Alalwan HA; Alkhars AM; Al Huwaiyshil AH; Alamri WM
    Cureus; 2020 Nov; 12(11):e11390. PubMed ID: 33312790
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Not all hip arthroplasties are created equal: increased complications and re-admissions after total hip arthroplasty for femoral neck fractures compared with osteoarthritis.
    Charette RS; Sloan M; Lee GC
    Bone Joint J; 2019 Jun; 101-B(6_Supple_B):84-90. PubMed ID: 31146554
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Activin-A is elevated in patients with thalassemia major and double heterozygous sickle cell/beta-thalassemia and correlates with markers of hemolysis and bone mineral density.
    Voskaridou E; Ntanasis-Stathopoulos I; Christoulas D; Dimopoulou M; Komninaka V; Repa K; Papatheodorou A; Terpos E
    Ann Hematol; 2019 Jul; 98(7):1583-1592. PubMed ID: 31041514
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.